MedPath

Effectiveness of the education based on empowerment for pregnant women on their empowerment and anxiety

Phase 2
Conditions
Anxiety.
Generalized anxiety disorder
Registration Number
IRCT201506042248N16
Lead Sponsor
Vice chancellor for research, Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
70
Inclusion Criteria

Iranian pregnant women; The first pregnancy; A low-risk pregnancy; A mild to moderate anxiety according to Spieberger Anxiety Scale; Gestational age 20 to 24 weeks; The lack of use particular drug; No history of mental health problems or hospitalization due to mental health problems; Age between 18 to 35 years; With literacy; Singleton pregnancy; No accidents in the last 3 months for the individual and first degree relatives. Exclusion criteria: The presence of known physical and mental illness such as diabetes; heart disease and psychosis including schizophrenia and paranoia that requires special medication and care; People who are treated for anxiety disorders; During the study; mothers who are involved by complication of pregnancy such as hypertension, toxemia of pregnancy; gestational diabetes; intrauterine fetal death; premature labor; Mothers who don’t desire to continue; Women who do not attend at least two sessions of training sessions.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pregnant women empowerment. Timepoint: Before the intervention, immediately and 8 weeks after the intervention. Method of measurement: Pregnant women empowerment questionair.
Secondary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: Before the intervention, immediately and 8 weeks after the intervention. Method of measurement: Spielberger State-Trait Anxiety Inventory (STAI).
© Copyright 2025. All Rights Reserved by MedPath